Cyfuse Biomedical K.K Balance Sheet Health
Financial Health criteria checks 5/6
Cyfuse Biomedical K.K has a total shareholder equity of ¥3.0B and total debt of ¥808.0M, which brings its debt-to-equity ratio to 27%. Its total assets and total liabilities are ¥3.9B and ¥908.0M respectively.
Key information
27.0%
Debt to equity ratio
JP¥808.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥3.56b |
Equity | JP¥3.00b |
Total liabilities | JP¥908.00m |
Total assets | JP¥3.90b |
Financial Position Analysis
Short Term Liabilities: 4892's short term assets (¥3.7B) exceed its short term liabilities (¥568.0M).
Long Term Liabilities: 4892's short term assets (¥3.7B) exceed its long term liabilities (¥340.0M).
Debt to Equity History and Analysis
Debt Level: 4892 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 4892's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4892 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4892 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 8.3% each year